VBI Vaccines (NASDAQ:VBIV) just reported results for the fourth quarter of 2023.
- VBI Vaccines reported earnings per share of -1 cent. This was above the analyst estimate for EPS of -22 cents.
- The company reported revenue of $853,000.
- This was 84.09% worse than the analyst estimate for revenue of $5.36 million.